Send the following on WhatsApp
Continue to ChatThe inhibitory activity of Ruxolitinib against COVID-19 major protease enzyme and SARS CoV-2 spike glycoprotein: A molecular docking study - https://dergipark.org.tr/en/pub/ojn/issue/75521/1134119
The inhibitory activity of Ruxolitinib against COVID-19 major protease enzyme and SARS CoV-2 spike glycoprotein: A molecular docking study - https://dergipark.org.tr/en/pub/ojn/issue/75521/1134119